Movin' on up the ladder! News out!PUF Ventures to Submit Confirmation of Readiness for Licence Under the ACMPR for London, Ontario Facility VANCOUVER, Jan. 26, 2018 /CNW/ - PUFVentures Inc. ("PUF"or the"Company") (CSE:PUF) (Frankfurt:PU3) (OTCPK:PUFXF),an advanced Access to Cannabis for MedicalPurposes Regulations ("ACMPR") licenseapplicant, is pleased to announcethat in responseto Health Canada's January 25, 2018 announcement regarding changes to the physicalsecurity requirement under the ACMPR, the Company is moving to immediately completethe video recording for the Confirmation ofReadiness submission and callfora HealthCanadainspection ofits London, Ontario facility. "Iamvery pleased to be moving to preparethe Confirmation ofReadiness for our London, Ontario facility as ourexisting security systemmeets HealthCanada's realigned requirements,"said Derek Ivany, Presidentand CEO ofPUF Ventures Inc. "For over 18 months the main goal ofthe Company has been to earn thelicenseto produce medicalcannabis inCanada. The Confirmation ofReadiness submission to HealthCanadaisa significantmilestonefor the Company and its shareholders. The Company hascomealongway and welook forward to initiating production in the near future." The Companywasadvised by the Office ofMedicalCannabis that HealthCanada had issued an announcement on January 25, 2018, regarding two targeted changes to physicalsecurity requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The changes will help to align the physicalsecurity requirements with theevidence ofactualrisks to publicsafetywithout imposing an unjustifiable burden on regulated parties. Thestatementmodifies thesecuritymeasures necessary for: areas wherecannabis plantsarecultivated, propagated, harvested or trimmed and to areas wherecannabis seedsare present or stored,and the vaultand storageareas. PUF's London, Ontario facility has the most up-to-date growing and security technologiesavailable. Thesecurity systemmeets orexceedsall requirements demand byHealthCanada. The growing facilitymeets the highest level of pharmaceuticalstandardsand featuresastate-of-the-art HVAC and Surna Water Chilled Climate Controlsystem. Thesesystems providethe backbone ofthefacility'sautomated controlfor temperature, light, humidity,carbon dioxide,and special ventilation for bacteriaregulation. growlights, tracking softwareand auxiliary hardware havealso been installed. Thefacilitywill havean annual production ofapproximately 600 kilograms ofmedicalcannabis. About PUFVentures Inc. PUF Ventures Inc. isa growth oriented and diversified company focused on theinternationalcannabis industry. It has ownership in several cannabiscompanies:AAAHeidelberg, Solaris Nutraceuticals PtyLtd.,and Natures Hemp Corp.,and isactively pursuing other opportunities within theindustry. PUF hasan option to purchase 100%ofAAAHeidelberg Inc.,a private Ontario company and advanced applicant foran ACMPRlicense. Currently, AAAHeidelberg has not received alicensefromHealthCanada. PUF is publicly traded under thefollowing symbols: CSE:PUF, Frankfurt:PU3 and OTCPK:PUFXF. For moreinformation please visit:www.puf.ca. ON BEHALF OF THEBOARDOF DIRECTORS Derek Ivany President&CEO No stock exchange or securities regulatory authority has reviewed or accepted responsibilityfor the adequacy or accuracy of this release. Some of thestatementscontained in this release areforward-looking statements, such asestimates and statements that describethe Issuer's future plans, objectives or goals, including words to theef ect that theIssuer or management expects a stated condition or result to occur. Sinceforward-looking statements address futureevents and conditions, bytheirvery nature, theyinvolveinherent risks and uncertainties. SOURCE PUF Ventures Vieworiginalcontent: https://www.newswire.ca/en/releases/archive/January2018/26/c2867.html %SEDAR: 00022839E Forfurtherinformation: PUF Ventures Inc., E:ir@puf.ca, T:(800) 783-6056 CO:PUF Ventures CNW 08:30e 26-JAN-18